IAS

IAS
July 23-26, 2023
Brisbane, Australia

International AIDS Society .

Explore more information for Gilead HIV / AIDS therapies
Material Type
Filter by Keyword(s)

Filter results with keywords such as:

  • Name of author(s)
  • Disease state
  • Indication
  • Trial phase
  • Trial name
  • Trial date

Note: Multiple keywords can be applied at the same time.

    Results (11)

    RECOMMENDATIONS FOR MISSED ORAL LENACAPAVIR LOADING DOSES USING POPULATION-PHARMACOKINETICS- BASED SIMULATIONS

    • Author(s): Singh, R
    • sunlenca
    • HIV / AIDS

    PHARMACOKINETIC BRIDGING WITH ORAL LENACAPAVIR FOR MISSED SUBCUTANEOUS Q6M DOSING

    • Author(s): Jogiragu, V
    • sunlenca
    • HIV / AIDS

    PATIENT-REPORTED OUTCOMES FROM THE CAPELLA CLINICAL TRIAL OF HEAVILY TREATMENT-EXPERIENCED ADULTS LIVING WITH HIV

    • Author(s): Ramgopal, M
    • sunlenca
    • HIV / AIDS

    WEIGHT CHANGE AND METABOLIC ASSESSMENT OF VIROLOGICALLY SUPPRESSED CHILDREN WITH HIV AGED ≥2 YEARS AND WEIGHING 14 TO <25 KG WHO RECEIVED A TAF-CONTAINING REGIMEN

    • Author(s): Natukunda, E
    • biktarvy
    • genvoya
    • HIV / AIDS

    LONGITUDINAL LYMPHOCYTE DYNAMICS IN VIROLOGICALLY SUPPRESSED CHILDREN WITH HIV INITIATING SINGLE-TABLET E/C/F/TAF

    • Author(s): Rakhmanina, N
    • genvoya
    • HIV / AIDS

    COMPARISON OF LONG-ACTING LENACAPAVIR PHASE 2/3 REGIMEN VS SIMPLIFIED REGIMEN USING POPULATION-PK ANALYSIS AND SIMULATION

    • Author(s): Shaik, N
    • sunlenca
    • HIV / AIDS

    LENACAPAVIR ORAL BRIDGING (300 MG QW) MAINTAINS EFFICACY WITH A SIMILAR SAFETY PROFILE WHEN SC LEN CANNOT BE ADMINISTERED

    • Author(s): Ogbuagu, O
    • sunlenca
    • HIV / AIDS
    • Oral

    WEEK 96 RESULTS OF ALLIANCE, A PHASE 3, RANDOMIZED, DOUBLE-BLIND STUDY COMPARING B/F/TAF VERSUS DTG+F/TDF IN TREATMENT-NAÏVE HIV- 1/HEPATITIS B (HBV) COINFECTION

    • Author(s): Avihingsanon, A
    • biktarvy
    • HIV / AIDS

    PHARMACOKINETICS, SAFETY, AND EFFICACY OF B/F/TAF IN VIROLOGICALLY SUPPRESSED PREGNANT WOMEN WITH HIV

    • Author(s): Zhang, H
    • biktarvy
    • HIV / AIDS

    PREEXISTING AND POSTBASELINE RESISTANCE ANALYSES IN POOLED PEDIATRIC STUDIES OF EMTRICITABINE/TENOFOVIR ALAFENAMIDE (F/TAF)-BASED ANTIRETROVIRAL THERAPY (ART)

    • Author(s): Andreatta, K
    • descovy
    • HIV / AIDS

    HEALTHCARE PROVIDER EXPERIENCE OF ADMINISTERING LONG-ACTING LENACAPAVIR FOR PEOPLE WITH HIV WITH HEAVY TREATMENT EXPERIENCE ENGAGED THROUGH A COMPASSIONATE USE PROGRAM IN THE UNITED STATES

    • Author(s): Herbst, A
    • sunlenca
    • HIV / AIDS